English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Shire
+
Technology/Innovation
Nicholas Gueguen
| Jun 30, 2017
Shire study sees reduction in hereditary angioedema episodes using lanadelumab
+
Technology/Innovation
Ruth de Jauregui
| May 3, 2017
Study indicates one bleeding incident every 3-15 seconds among hemophiliacs
+
Community
Robert Hadley
| Apr 28, 2017
Shire’s hashtag campaign focusing on primary immunodeficiency
Keri Carbaugh
| Feb 6, 2017
Shire takes lead on rare conditions, CEO says
+
Community
Keri Carbaugh
| Jan 18, 2017
Shire again offers scholarship for students with ADHD
+
Community
Amanda Rupp
| Jun 11, 2016
Shire shareholders approve Baxalta merger
+
Regulatory
Amanda Rupp
| Jun 7, 2016
CHMP gives positive opinion of short bowl syndrome pediatric medicine
+
Technology/Innovation
Amanda Rupp
| Apr 17, 2016
Shire sends application to FDA for chewable Vyvanse tablets
Trending
+
Pharmaceuticals
Patient Daily
| Aug 4, 2026
Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+
Pharmaceuticals
Patient Daily
| Aug 6, 2026
FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+
Regulatory
M. R. Armstrong
| Aug 4, 2026
Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+
Pharmaceuticals
Patient Daily
| Aug 5, 2026
Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes
